1.29
-0.05(-3.73%)
Currency In USD
Previous Close | 1.34 |
Open | 1.33 |
Day High | 1.4 |
Day Low | 1.27 |
52-Week High | 3.09 |
52-Week Low | 0.26 |
Volume | 1.58M |
Average Volume | 917,684 |
Market Cap | 237.22M |
PE | -5.86 |
EPS | -0.22 |
Moving Average 50 Days | 1.1 |
Moving Average 200 Days | 1.13 |
Change | -0.05 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $129.78 as of June 01, 2025 at a share price of $1.29. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 2 years ago, it would be worth $120 as of June 01, 2025 at a share price of $1.29.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
GlobeNewswire Inc.
May 30, 2025 3:01 PM GMT
WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™. Tevogen.AI™ aims to integ
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow
GlobeNewswire Inc.
May 23, 2025 7:49 PM GMT
WARREN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced a planned expansion of TVGN 489’s target population to include patients 65 and older. As previously reported in Octobe
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting
GlobeNewswire Inc.
May 22, 2025 5:21 PM GMT
WARREN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that it will provide several updates to stockholders in advance of the Company’s upcoming Annual Meeting of Stockholde